Drug maker Aurobindo Pharma USA, Inc. has recalled 80 lots of Amlodipine Valsartan due to possible cancer risk. Valsartan is a drug used to treat high blood pressure and heart failure.
According to the Food & Drug Administration (FDA), Aurobindo Pharma detected trace amounts of a carcinogen known as N-nitrosodiethylamine (NDEA) in Valsartan tablets.
The carcinogen NDEA can be found naturally in foods and the environment. But it is often added to gasoline and used as a stabilizer for industry materials.
Human carcinogens are substances that can harm cells and DNA, which could lead to cancer.
Aurobindo Pharma has voluntarily recalled Valsartan and there are no reports of illnesses related to the recall.
The recalls includes the following drugs:
Patients can report any side-effects to the FDA MedWatch.
Doctors have prescribed Valsartan to patients throughout the United States.
Patients should work with their doctor and pharmacist to find a replacement for Valsartan before stopping the drug.
Patients can contact Aurobindo Pharma USA, Inc by email or phone with any questions regarding the recall.
Thomas J. Henry Injury Attorneys are leaders in the area of drug and product liability litigation. Our Defective Drug and Products Division have extensive knowledge and resources in order to represent our clients efficiently and aggressively. The Defective Drug and Products Division represent a multitude of people who are battling against manufacturers of medical devices and/or defective pharmaceuticals.
If you or a loved one have been injured by or have developed serious side-effects from the use of recalled medications or pharmaceuticals, contact Thomas J. Henry immediately. We represent clients/victims all over the country. We are available 24/7, nights and weekends.